Monday, October 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 3, 2026

Stock market today: Dow plunges over 1,000 points, S&P 500 and Nasdaq sink as oil surges amid war worries

View original at finance.yahoo.com
Stock market today: Dow plunges over 1,000 points, S&P 500 and Nasdaq sink as oil surges amid war worries US stocks sold off on Tuesday after Israel and US jets launched new strikes on Iran, as the widening conflict stoked worries about a drawn-out regional war…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • US willing to deploy ground troops in Iran for whatever duration necessary

    80% confidence
  • Markets will take initial cues from leaders running point on the war (Trump, Hegseth)

    80% confidence
  • Target should stay in penalty box and is a 'prove it' stock; investors should favor Walmart or Costco on pullbacks

    80% confidence
  • Target market share was at least flat during holiday quarter, pointing to slightly softer customer demand for the industry

    80% confidence
  • Best Buy expects first quarter same-store sales to return to growth, rising 1%

    80% confidence
  • First quarter lift expected to banks' trading business from increased volatility across markets from Iran war

    80% confidence
  • Trump administration will roll out program to mitigate rising energy costs, hardest military hits on Iran yet to come

    80% confidence
  • Since 2009, S&P 500 has seen more than 30 pullbacks of greater than 5%, suggesting stocks can be resilient in face of bad news

    80% confidence
  • 10% increase in crude oil prices typically raises core inflation by 4 basis points and headline inflation by 20-30 basis points

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Stock market today: Dow plunges over 1,000 points, S&P 500 and Nasdaq sink as oil surges amid war worries — Source | Via News | ViaNews Market